Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
HSD10 disease, neonatal type is the most severe form of HSD10 disease, a rare neurometabolic disorder. It is characterized by onset of severe metabolic/lactic acidosis, neurological and psychomotor delay, seizures and severe progressive hypertrophic cardiomyopathy in the neonatal period. Hepatic involvement and coagulopathy are rare. The disease is fatal within the first months of life.
Biomarker and diagnostic research for HSD10 disease, neonatal type has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for HSD10 disease, neonatal type.
3 publications have been identified in PubMed for HSD10 disease, neonatal type. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
Kubo R (2025). [PMID: 41179105](https://pubmed.ncbi.nlm.nih.gov/41179105/). *Cureus*. [Case Report / Case Series]
Duan T (2025). [PMID: 40008813](https://pubmed.ncbi.nlm.nih.gov/40008813/). *Chin Med J (Engl)*. [Review / Meta-Analysis]
Veldman A (2024). [PMID: 39846587](https://pubmed.ncbi.nlm.nih.gov/39846587/). *Int J Neonatal Screen*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:46 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about HSD10 disease, neonatal type